skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
01/22/2019
Application #:
15571291
Filing Dt:
11/02/2017
Publication #:
Pub Dt:
08/23/2018
Inventors:
Johan Olof BRODDEFALK, Hans Fredrik EMTENÄS, Kenneth Lars GRANBERG et al
Title:
PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
Assignment: 1
Reel/Frame:
044019/0635Recorded: 11/02/2017Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/15/2016
Exec Dt:
02/12/2016
Assignee:
SE-151 85
SODERTALJE, SWEDEN
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878
Assignment: 2
Reel/Frame:
044256/0893Recorded: 11/30/2017Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/12/2016
Exec Dt:
02/15/2016
Exec Dt:
02/12/2016
Assignee:
SE-151 85
SODERTALJE, SWEDEN
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878
Assignment: 3
Reel/Frame:
044020/0991Recorded: 11/02/2017Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/13/2016
Exec Dt:
05/13/2016
Exec Dt:
05/13/2016
Exec Dt:
05/13/2016
Exec Dt:
05/13/2016
Exec Dt:
05/13/2016
Exec Dt:
05/13/2016
Assignee:
SE-151 85
SODERTALJE, SWEDEN
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878

Search Results as of: 06/20/2024 03:41 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT